Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$0.22 - $0.66 $5,822 - $17,468
-26,467 Reduced 39.5%
40,538 $15,000
Q3 2023

Nov 13, 2023

BUY
$0.2 - $1.78 $8,602 - $76,557
43,010 Added 179.25%
67,005 $14,000
Q2 2023

Aug 10, 2023

BUY
$1.02 - $1.89 $2,102 - $3,895
2,061 Added 9.4%
23,995 $41,000
Q1 2023

May 12, 2023

BUY
$1.0 - $1.35 $6,405 - $8,646
6,405 Added 41.25%
21,934 $23,000
Q4 2022

Feb 10, 2023

BUY
$0.87 - $1.33 $1,964 - $3,003
2,258 Added 17.01%
15,529 $16,000
Q3 2022

Nov 14, 2022

SELL
$1.02 - $1.26 $780 - $963
-765 Reduced 5.45%
13,271 $16,000
Q2 2022

Aug 10, 2022

SELL
$0.91 - $2.01 $4,035 - $8,914
-4,435 Reduced 24.01%
14,036 $14,000
Q1 2022

May 04, 2022

SELL
$1.22 - $2.03 $14,365 - $23,903
-11,775 Reduced 38.93%
18,471 $33,000
Q3 2021

Nov 05, 2021

SELL
$2.12 - $2.76 $71,251 - $92,760
-33,609 Reduced 52.63%
30,246 $66,000
Q2 2021

Aug 02, 2021

SELL
$1.78 - $2.76 $2,792 - $4,330
-1,569 Reduced 2.4%
63,855 $158,000
Q1 2021

May 13, 2021

SELL
$0.94 - $3.31 $3,008 - $10,592
-3,200 Reduced 4.66%
65,424 $147,000
Q4 2020

Feb 10, 2021

SELL
$0.7 - $1.58 $5,705 - $12,877
-8,150 Reduced 10.62%
68,624 $89,000
Q3 2020

Nov 12, 2020

BUY
$0.61 - $1.6 $16,555 - $43,424
27,140 Added 54.68%
76,774 $55,000
Q2 2020

Aug 14, 2020

BUY
$0.56 - $1.41 $444 - $1,119
794 Added 1.63%
49,634 $64,000
Q1 2020

May 18, 2020

BUY
$0.51 - $1.08 $24,908 - $52,747
48,840 New
48,840 $30,000

Others Institutions Holding OTLK

About Outlook Therapeutics, Inc.


  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.17B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.